Back to All Services
Our Services
Health Economics Research
At Medicys we partner with, and are preferred suppliers to, many leading health economics firms who focus on measuring and valuing the outcomes of healthcare interventions and who seek to understand how to navigate regulatory frameworks and Health Technology Assessment processes.
Specifically, our pricing and market access specialists recruit, interview and report on our network of local, regional and national payers (and ex payers) and Payer Advising Key Opinion Leaders (PA-KOLs) on topics such as:
- Economic Evaluation
- Cost of illness
- Cost comparison, effectiveness, utility and benefit
- Thresholds and opportunity costs
- Value driven healthcare systems
- Health Policy and Regulatory frameworks
- Approval and labelling
- Pricing Policy and pricing Schemes
- Reimbursement and access
- Insurance systems and national healthcare
- Public spending and national health expenditures
- Procurement systems
- Risk sharing approaches
- Health Technology Assessment
- Systems and structure
- Value framework and dossier format
- Decisions and deliberative processes
Our projects in this discipline usually take the form of Web Assisted Telephone Depth Interviews (WATDIs), online groups or advisory boards (digital or in person).
Related Work
See all Work
health economics research
Acute Alcoholic Hepatitis
To assess the unmet need, value perception, and pricing and market access potential of a drug in clinical development
health economics research
+1
regional and national payers
Discuss a new respiratory Product ‘X’, a triple combination for the treatment of asthma and understand how this product might be positioned, gain access and priced in the future treatment landscape. Uncover perceptions around asthma disease burden, unmet needs, current therapies and required evidence to support the approval/reimbursement/funding of Product X in the future
health economics research
To discuss and understand the use of anaesthetic products. This will require a thorough understanding of current usage, procurement, and supply of anaesthetic products; as well as an informed perception on how the therapy area is evolving and might develop in the future.
health economics research
+2
Key Opinion Leaders (KOLs), respiratory physicians
Talking to key decision makers in the area of respiratory infections, specifically SARS-CoV2, respiratory pandemics and also infectious rhinitis and rhinosinusitis. Understand views on the treatment and management of respiratory infections, and the impact that a new treatment may have on this therapeutic area in the future. Discuss the potential pricing and reimbursement implications a new product may have on this therapy area
Request a quote
